| 0.4215 0 (0%) | 01-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.6 |
1-year : | 0.7 |
| Resists | First : | 0.51 |
Second : | 0.6 |
| Pivot price | 0.02 |
|||
| Supports | First : | 0.19 |
Second : | 0 |
| MAs | MA(5) : | 0.08 |
MA(20) : | 0.02 |
| MA(100) : | 0.37  |
MA(250) : | 1.92 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 27 |
D(3) : | 9 |
| RSI | RSI(14): 94.6 |
|||
| 52-week | High : | 8.48 | Low : | 0 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ CMAX ] has closed above the upper band by 43.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 27.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.52 - 0.52 | 0.52 - 0.52 |
| Low: | 0.42 - 0.42 | 0.42 - 0.42 |
| Close: | 0.42 - 0.42 | 0.42 - 0.42 |
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
Sun, 17 Nov 2024
CareMax Seeks Restructuring With Heavy Debt Load Overshadowing Assets - Finimize
Sun, 17 Nov 2024
CareMax Files Chapter 11, Sells Medicare Business to Revere Medical in $30.5M Deal - Stock Titan
Mon, 22 Jul 2024
CareMax Shares Are Up By More Than 200%: What You Need To Know - Benzinga
Thu, 11 Jul 2024
CareMax secures $20M in new financing and extends loan terms - Investing.com
Sat, 11 May 2024
CareMax (CMAX) Stock Forecast and Price Target 2025 - MarketBeat
Mon, 18 Mar 2024
Caremax’s Financial Stability Threatened by Partner Risks Post-Steward Acquisition - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 4 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 24.1 (%) |
| Held by Institutions | 39.7 (%) |
| Shares Short | 210 (K) |
| Shares Short P.Month | 124 (K) |
| EPS | -208.92 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -38.73 |
| Profit Margin | -99.8 % |
| Operating Margin | -10 % |
| Return on Assets (ttm) | -10.6 % |
| Return on Equity (ttm) | -328.5 % |
| Qtrly Rev. Growth | -11.5 % |
| Gross Profit (p.s.) | -6.82 |
| Sales Per Share | 205.91 |
| EBITDA (p.s.) | -28.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -52 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.02 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|